The deputy and executive assistant to the head of the Food and Drug Organization pointed out the high currency expenditure for plasma-derived products such as IVIG, albumin, and coagulation factors, stating that approximately 300 million dollars is spent annually on the import of these products. Given their critical importance, the development of the plasma industry and the move towards self-sufficiency in this area is essential.
300 Million Dollars in Currency Expenditure for Plasma-Derived Products / Self-Sufficiency in the Plasma Industry on the Agenda
Iran's Food and Drug Organization highlights the significant annual cost of importing plasma-derived products, amounting to 300 million dollars. The emphasis on developing the domestic plasma industry aims to achieve self-sufficiency, which is crucial for the country's healthcare needs.
👥 Key Players
📰 What Happened
Iran's Food and Drug Organization reported an annual expenditure of approximately 300 million dollars on imported plasma-derived products. They emphasized the need to develop domestic production to achieve self-sufficiency in this critical healthcare sector.
- 300 million dollars is spent annually on importing plasma-derived products like IVIG and albumin.
- The development of the plasma industry is deemed essential for healthcare self-sufficiency.
💡 Why It Matters
📚 Background
Plasma-derived products are essential for treating various medical conditions, and reliance on imports can be risky, especially under sanctions. Developing domestic production is a strategic priority for Iran's healthcare system.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%